Medicare Enrolled
Dr. Joel Vandersluis, M.D.
Neurology · Dayton, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Vandersluis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vandersluis?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vandersluis
Dr. Joel Vandersluis is a neurology specialist in Dayton, OH, with 21 years of NPI registration. Based on federal Medicare data, Dr. Vandersluis performed 2,020 Medicare services across 1,666 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vandersluis received a total of $26,704 from 73 pharmaceutical and/or device companies across 1032 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vandersluis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 11% volume in OH
$26,704 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,020
Medicare services
Top 11% in OH for neurology
1,666
Unique beneficiaries
$119
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~96 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
470 | $72 | $224 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
375 | $91 | $200 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
221 | $48 | $175 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
202 | $138 | $401 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
174 | $152 | $324 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
164 | $284 | $400 |
| New patient office visit, complex (60-74 min) | 141 | $157 | $350 |
| Complete ultrasound of brain blood flow An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation. |
87 | $195 | $415 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
79 | $163 | $363 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
67 | $116 | $300 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $40 | $150 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
12 | $34 | $94 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$26,704
Total received (2018-2024)
Avg $3,815/year across 7 years
Top 18% in OH for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
73
Companies
1,032
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,738 (70.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$7,967 (29.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,831
2023
$2,805
2022
$2,827
2021
$7,552
2020
$3,292
2019
$2,079
2018
$5,318
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
MDD US Operations, LLC
$350
Neurocrine Biosciences, Inc.
$311
PFIZER INC.
$233
ABBVIE INC.
$212
Teva Pharmaceuticals USA, Inc.
$208
Novartis Pharmaceuticals Corporation
$173
Eisai Inc.
$168
Lilly USA, LLC
$150
Takeda Pharmaceuticals U.S.A., Inc.
$106
Vanda Pharmaceuticals Inc.
$105
Biogen, Inc.
$90
Novo Nordisk Inc
$81
Celgene Corporation
$77
ARGENX US, INC.
$76
BANNER LIFE SCIENCES, LLC
$76
Otsuka America Pharmaceutical, Inc.
$69
ACADIA Pharmaceuticals Inc
$66
EMD Serono, Inc.
$56
UCB, Inc.
$56
Alexion Pharmaceuticals, Inc.
$44
Lundbeck LLC
$30
TG Therapeutics, Inc.
$24
Neurelis, Inc.
$21
Genentech USA, Inc.
$16
Ipsen Biopharmaceuticals, Inc
$15
MITSUBISHI TANABE PHARMA AMERICA, INC.
$15
Top 3 companies account for 31.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$4,731
Allergan, Inc.
$4,112
AbbVie Inc.
$3,950
Teva Pharmaceuticals USA, Inc.
$1,585
Biogen, Inc.
$1,004
EMD Serono, Inc.
$919
Genentech USA, Inc.
$763
Lilly USA, LLC
$650
Neurocrine Biosciences, Inc.
$624
PFIZER INC.
$534
ABBVIE INC.
$475
MDD US Operations, LLC
$455
Sunovion Pharmaceuticals Inc.
$449
GENZYME CORPORATION
$417
Amgen Inc.
$337
Eisai Inc.
$327
ACADIA Pharmaceuticals Inc
$314
SK Life Science, Inc.
$300
Janssen Pharmaceuticals, Inc
$298
UCB, Inc.
$295
Biohaven Pharmaceutical Holding Company Ltd.
$268
Biohaven Pharmaceuticals, Inc.
$256
Lundbeck LLC
$234
Neurelis, Inc.
$217
Acorda Therapeutics, Inc
$205
Takeda Pharmaceuticals U.S.A., Inc.
$196
ARGENX US, INC.
$192
Adamas Pharmaceuticals, Inc.
$179
NOVARTIS PHARMACEUTICALS CORPORATION
$140
Celgene Corporation
$130
Supernus Pharmaceuticals, Inc.
$124
Alnylam Pharmaceuticals Inc.
$119
Otsuka America Pharmaceutical, Inc.
$117
CSL Behring
$116
Avanir Pharmaceuticals, Inc.
$107
Vanda Pharmaceuticals Inc.
$105
Alexion Pharmaceuticals, Inc.
$103
EISAI INC.
$99
ARBOR PHARMACEUTICALS, INC.
$85
Novo Nordisk Inc
$81
BANNER LIFE SCIENCES, LLC
$76
Amneal Pharmaceuticals LLC
$72
Merz North America, Inc.
$60
Impax Laboratories, Inc.
$59
Bayer HealthCare Pharmaceuticals Inc.
$57
Allergan Inc.
$52
Mallinckrodt Enterprises LLC
$51
Corium, LLC
$49
Avion Pharmaceuticals
$49
Upsher-Smith Laboratories LLC
$43
GE HEALTHCARE
$40
GE HealthCare
$38
Octapharma USA, Inc.
$36
Aprecia Pharmaceuticals, LLC
$34
Mylan Pharmaceuticals Inc.
$33
Mallinckrodt LLC
$31
Horizon Therapeutics plc
$29
Otsuka Pharmaceutical Development & Commercialization, Inc.
$29
Nevro Corp.
$29
Mallinckrodt Hospital Products Inc.
$27
TG Therapeutics, Inc.
$24
Abbott Laboratories
$22
AstraZeneca Pharmaceuticals LP
$19
IMPEL PHARMACEUTICALS INC.
$17
Banner Life Sciences, LLC
$16
Ipsen Biopharmaceuticals, Inc
$15
MITSUBISHI TANABE PHARMA AMERICA, INC.
$15
Vertical Pharmaceuticals, LLC
$14
CATALYST PHARMACEUTICALS, INC.
$12
AbbVie, Inc.
$12
Medtronic Vascular, Inc.
$12
Daiichi Sankyo Inc.
$11
Arbor Pharmaceuticals, Inc.
$11
Top 3 companies account for 47.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · COMIRNATY · COPAXONE · DUOPA · Dhivy · Duopa · Dysport · EMGALITY · FIRDAPSE · Fycompa · GAMMAGARD · GILENYA · GIVLAARI · GOCOVRI · Glatiramer Acetate · Gocovri · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · INJECTAFER · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · KYNMOBI · LUMIZYME · LYRICA · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · NAMZARIC · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONPATTRO · Ocrevus · Omnia · Ongentys · PANZYGA · PAXLOVID · PLEGRIDY · POMPE - DISEASE · PONVORY · Ponvory · Privigen · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · RELEXXII · REXULTI · RYTARY · Rebif · Reveal LINQ · Rystiggo · SOLIRIS · Spritam · TECFIDERA · TROKENDI XR · TYSABRI · Tosymra Sumatriptan Nasal Spray · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XADAGO · XEOMIN · ZEPOSIA · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (70%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
61
Per 100K population
11.4
County median income
$64,403
Nearest hospital
KETTERING HEALTH MAIN CAMPUS
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Vandersluis is a clinical cardiology specialist, with above-average Medicare volume (top 11% in OH), with low-engagement industry engagement in the top 18% of OH peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Vandersluis experienced with electromyography of arm or leg muscles?
Based on Medicare claims data, Dr. Vandersluis performed 470 electromyography of arm or leg muscles services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vandersluis receive payments from pharmaceutical companies?
Yes. Dr. Vandersluis received a total of $26,704 from 73 companies across 1,032 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vandersluis's costs compare to other neurologists in Dayton?
Dr. Vandersluis's average Medicare payment per service is $119. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vandersluis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Dayton
Browse neurologists in Dayton ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in OH
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in OH
Which OH neurologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology